slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8.080 KRW | +0,12% |
|
-0,74% | -21,32% |
2023 | Dongwha Pharm.Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Vakgebied
Aantal werknemers: 810
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
92,8
%
| 315 928 | 92,8 % | 335 135 | 92,8 % | +6,08% |
Medical Equipment
7,4
%
| 24 614 | 7,2 % | 26 561 | 7,4 % | +7,91% |
Consolidated Adjustment
-0,2
%
| -116 | 0,0 % | -587 | -0,2 % | +406,78% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
95,0
%
| 321 926 | 94,6 % | 342 936 | 95,0 % | +6,53% |
Overseas
5,0
%
| 18 501 | 5,4 % | 18 173 | 5,0 % | -1,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun-Ha Yoo
CEO | Chief Executive Officer | 60 | - |
Ma-Se Lee
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
Dae-Hyun Kim
BRD | Director/Board Member | 47 | - |
In-Ho Yoon
BRD | Director/Board Member | 40 | - |
Hyun-Gyeong Yoon
PRN | Corporate Officer/Principal | 44 | - |
Do-Joon Yoon
PRN | Corporate Officer/Principal | 72 | - |
Gil-Joon Yoon
PRN | Corporate Officer/Principal | 67 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Do-Joon Yoon
PRN | Corporate Officer/Principal | 72 | - |
In-Ho Yoon
BRD | Director/Board Member | 40 | - |
Sem-An Oh
BRD | Director/Board Member | 68 | 21-03-19 |
Jun-Ha Yoo
CEO | Chief Executive Officer | 60 | - |
Gwang-Jun Kim
BRD | Director/Board Member | 47 | 19-03-20 |
Na-Na Geum
BRD | Director/Board Member | 41 | 19-03-20 |
Dae-Hyun Kim
BRD | Director/Board Member | 47 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 931 470 | 17 182 851 ( 61,52 %) | 213 540 ( 0,7645 %) | 61,52 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
WHAN IN PHARM CO.,LTD. 1.88% | 350 000 | 1.88% | 3 660 395 $ |
DONGWHA PHARM.CO.,LTD 0.90% | 252 340 | 0.90% | 1 509 064 $ |
JETEMA, CO., LTD. 0.62% | 110 000 | 0.62% | 1 244 954 $ |
GENEXINE, INC. 0.22% | 90 013 | 0.22% | 462 238 $ |
Bedrijfsgegevens
DONG WHA PHARM Co., Ltd.
6-8/F, FastFive Tower 24 Namdaemun-ro 9-gil
04522, Seoul
+
http://www.dong-wha.co.kr![Adres Dongwha Pharm.Co.,Ltd(A000020)](https://cdn.zonebourse.com/static/address/20699410.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,32% | 161 mln. | |
+20,78% | 43,29 mld. | |
+27,64% | 22,38 mld. | |
+19,25% | 15,51 mld. | |
+18,68% | 14,52 mld. | |
+54,64% | 12,93 mld. | |
-0,05% | 6,79 mld. | |
-11,39% | 6,56 mld. | |
+18,33% | 5,87 mld. | |
-8,87% | 5,73 mld. |
- Beurs
- Aandelen
- Koers A000020
- Onderneming Dongwha Pharm.Co.,Ltd